Oral Mucositis in Children with Leukemia Undergoing Chemotherapy: A Case Series
Keywords:
Mucositis, Stomatitis, Hematologic Diseases, Drug TherapyAbstract
Objective: To report nine cases of pediatric patients with Acute Lymphoid Leukemia (ALL) or Acute Myeloid Leukemia who developed severe oral mucositis (SOM) at the first week of chemotherapy. Material and Methods: The cases were selected from a sample of 105 children followed for 10 consecutive weeks. Hematological and personal data were obtained from the patient's medical records. The oral cavity was examined weekly using the modified Oral Assessment Guide. Results: More of the patients were male (55.6%), had black/brown skin (55.6%), with ALL (66.7%), and the mean age was 5.55. Two patients had values below normal for leukocytes, platelets, and creatinine over the follow-up. However, all patients showed changes in the normality of hematological data in most weeks. The most used chemotherapeutic agents were aracytin, etoposide, and methotrexate, known for their high stomatotoxic potential. Patients had 2 to 6 (mean of 4) episodes of SOM and 4 to 7 (mean of 5.5) episodes of OM. One patient at week 7, one patient at week 5, and one patient at weeks 2 and 10 did not have OM. Saliva (84 times) and lips (44 times) were the most affected items. Conclusion: The patients showed oscillations in the severity of oral mucositis and hematological parameters over the follow-up. All patients were exposed to stomatotoxic drugs during the initial phase of cancer treatment.
References
Madhusoodhan PP, Carroll WL, Bhatla T. Progress and prospects in pediatric leukemia. Curr Probl Pediatr Adolesc Health Care 2016; 46(7):229-41. https://doi.org/10.1016/j.cppeds.2016.04.003
Damascena LCL, de Lucena NNN, Ribeiro ILA, de Araujo TLP, de Castro RD, Bonan PRF, et al. Factors contributing to the duration of chemotherapy-induced severe oral mucositis in oncopediatric patients. Int J Environ Res Public Health 2018; 15(6):1153. https://doi.org/10.3390/ijerph15061153
Peng J, Shi Y, Wang J, Wang F, Dan H, Xu H, et al. Low-level laser therapy in the prevention and treatment of oral mucositis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 130(4):387-397.e9. https://doi.org/10.1016/j.oooo.2020.05.014
Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2(1):21-32; discussion 35-6.
Qutob AF, Gue S, Revesz T, Logan RM, Keefe D. Prevention of oral mucositis in children receiving cancer therapy: a systematic review and evidence-based analysis. Oral Oncol 2013; 49(2):102-7. https://doi.org/10.1016/j.oraloncology.2012.08.008
Docimo R, Anastasio MD, Bensi C. Chemotherapy-induced oral mucositis in children and adolescents: a systematic review. Eur Arch Paediatr Dent 2022; 23(4):501-11. https://doi.org/10.1007/s40368-022-00727-5
Damascena LCL, de Lucena NNN, Ribeiro ILA, Pereira TL, Lima-Filho LMA, Valença AMG. Severe oral mucositis in pediatric cancer patients: Survival analysis and predictive factors. Int J Environ Res Public Health 2020; 17(4):1235. https://doi.org/10.3390/ijerph17041235
Urtasun A, Olivera GG, Sendra L, Aliño SF, Berlanga P, Gargallo P, et al. Personalized medicine in infant population with cancer: Pharmacogenetic pilot study of polymorphisms related to toxicity and response to chemotherapy. Cancers 2023; 15(5):1424. https://doi.org/10.3390/cancers15051424
Triarico S, Agresti P, Rinninella E, Mele MC, Romano A, Attinà G, et al. Oral microbiota during childhood and its role in chemotherapy-induced oral mucositis in children with cancer. Pathogens 2022; 11(4):448. https://doi.org/10.3390/pathogens11040448
de Farias Gabriel A, Silveira FM, Curra M, Schuch LF, Wagner VP, Martins MAT, et al. Risk factors associated with the development of oral mucositis in pediatric oncology patients: systematic review and meta-analysis. Oral Dis 2022; 28(4):1068-84. https://doi.org/10.1111/odi.13863
Ribeiro ILA, Melo ACR, Limão NP, Bonan PRF, Lima Neto EA, Valença AMG. Oral mucositis in pediatric oncology patients: a nested case-control to a prospective cohort. Braz Dent J 2020; 31(1):78-88. https://doi.org/10.1590/0103-6440201802881
Ribeiro Júnior O, Borba AM, Guimarães Júnior J. Prevenção e tratamento da mucosite bucal: o papel fundamental do cirurgião-dentista: revisão. Rev Clín Pesq Odontol 2010; 6(1):57-62. [In Portuguese].
Cheng KK, Chang AM, Yuen MP. Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care. Eur J Cancer 2004; 40(8):1208-16. https://doi.org/10.1016/j.ejca.2003.10.023
Russi EG, Raber-Durlacher JE, Sonis ST. Local and systemic pathogenesis and consequences of regimen-induced inflammatory responses in patients with head and neck cancer receiving chemoradiation. Mediators Inflamm 2014; 2014:518261. https://doi.org/10.1155/2014/518261
Cheng KK, Lee V, Li CH, Goggins W, Thompson DR, Yuen HL, et al. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy. Oral Oncol 2011; 47(3):153-62. https://doi.org/10.1016/j.oraloncology.2010.11.019
Mathur VP, Dhillon JK, Kalra G. Oral health in children with leukemia. Indian J Palliat Care 2012; 18(1):12-8. https://doi.org/10.4103/0973-1075.97343
Ribeiro ILA, de Castro RD, Costa RC, Damascena LCL, de Lucena NNN, Maracajá PMB, et al. Integrated oral care contributes positively to the course of treatment of oncopediatric patients. Eur J Pediatr 2021; 180(9):2757-64. https://doi.org/10.1007/s00431-021-04024-z
Vanhoecke B, De Ryck T, Stringer A, Van de Wiele T, Keefe D. Microbiota and their role in the pathogenesis of oral mucositis. Oral Dis 2015; 21(1):17-30. https://doi.org/10.1111/odi.12224
Gandhi K, Datta G, Ahuja S, Saxena T, Datta AG. Prevalence of oral complications occurring in a population of pediatric cancer patients receiving chemotherapy. Int J Clin Pediatr Dent 2017; 10(2):166-71. https://doi.org/10.5005/iD-iournals-10005-1428
Instituto Nacional de Câncer. Ações de Enfermagem Para o Controle do Câncer: Uma Proposta de Integração Ensino-Serviço. 3. ed. atual. amp. Rio de Janeiro: INCA; 2008. [In Portuguese].
Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 2003; 39(2):91-100. https://doi.org/10.1016/s1368-8375(02)00033-7
Peterson DE, Keefe DM, Sonis ST. New frontiers in mucositis. Am Soc Clin Oncol Educ Book 2012; 545-51. https://doi.org/10.14694/EdBook_AM.2012.32.46
Garrocho-Rangel JA, Herrera-Moncada M, Márquez-Preciado R, Tejeda-Nava F, Ortiz-Zamudio JJ, Pozos-Guillén A. Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series. Eur J Paediatr Dent 2018; 19(3):239-42. https://doi.org/10.23804/ejpd.2018.19.03.13
Allen G, Logan R, Revesz T, Keefe D, Gue S. The prevalence and investigation of risk factors of oral mucositis in a pediatric oncology inpatient population: a prospective study. J Pediatr Hematol Oncol 2018; 40(1):15-21. https://doi.org/10.1097/MPH.0000000000000970
Hurrell L, Burgoyne LL, Logan RM, Revesz T, Gue S. Factors associated with oral mucositis severity in children who have received chemotherapy. J Pediatr Hematol Oncol 2022; 44(8):e1016-e1022. https://doi.org/10.1097/MPH.0000000000002392
Guimarães JR, Carvalho LG, Damascena LC, Sampaio ME, Ribeiro IL, Sousa SA, et al. The incidence of severe oral mucositis and its occurrence sites in pediatric oncologic patients. Med Oral Patol Oral Cir Bucal 2021; 26(3):e299-e303. https://doi.org/10.4317/medoral.24185
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pesquisa Brasileira em Odontopediatria e Clínica Integrada
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
